APA (7th ed.) Citation

P, B., A, Z., JA, B., J, A., S, B., DN, C., . . . WR, L. (2026). Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data. Clinical reviews in allergy & immunology, 69(1), . https://doi.org/10.1007/s12016-026-09179-x

Chicago Style (17th ed.) Citation

P, Busse, Zanichelli A, Bernstein JA, Anderson J, Betschel S, Castaner DN, Otule M, Piccolo T, and Lumry WR. "Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data." Clinical Reviews in Allergy & Immunology 69, no. 1 (2026). https://doi.org/10.1007/s12016-026-09179-x.

MLA (9th ed.) Citation

P, Busse, et al. "Lanadelumab Use for Hereditary Angioedema Long-Term Prophylaxis Over the Last 7 Years: A Narrative Review of Clinical and Real-World Data." Clinical Reviews in Allergy & Immunology, vol. 69, no. 1, 2026, https://doi.org/10.1007/s12016-026-09179-x.